Innovating Medical Technology

Based on its innovative MedTech platform for personalized patient support, Nia Health develops medical software. Nia Health’s end-to-end solutions are indication-specific and tailored to the individual needs of each patient.

Nia Health covers a wide variety of use cases in the dermatology and allergology space. Nia Health’s Digital Therapeutics (DTx) combine strong clinical validation with empowerment, gamification and machine learning.

It is Nia Health’s mission to provide a highly engaging and personalized patient experience that removes barriers to health behavior change.

First-hand patient behavior insights make the difference!

Solutions by Nia Health

Digital Therapeutics (DTx)

Nia Health’s expertise includes the development, market launch and continuous operation of scalable Digital Health Applications (DiGA). We meet the highest standards in quality management, data security and data protection. With regard to reimbursement options for DTx solutions, we have many years of experience and cooperate with a wide range of health insurance companies. Our solutions have already won numerous innovation awards.

Remote Patient Monitoring

Remote patient monitoring (RPM) opens up new opportunities for clinicians to assess patients’ conditions without having to be physically present in the same room. RPM means access to real-time medical information at a fingertip. Combined with Nia Health’s patient-centric solutions, this allows healthcare professionals to assess a patient’s condition from anywhere via PC or mobile devices. Thus, modifications within the treatment plan can be made in real time.

Digital Trial Tools

The requirements for combining, integrating and analysing complex data are growing: environmental factors, personal life circumstances as well as subjective concerns of the patient play an important role. Digital Trial Companions by Nia Health support clinical trials thanks to digital state-of-the-art data collection. The compliance of the study participants is increased through motivating interaction of our state-of-the-art clinical trial tools.

Individual solutions for individual needs

Patient Apps by Nia Health

Insights from medical data generated in the “real world” (real-world evidence) – give us unprecedented insights into the correlations around the incidence of diseases and symptoms.

The Eczema App

The award-winning eczema app Nia is the most used medical eczema app in Europe. Nia was the first app of its kind to be approved as a medical device. Six months after its release in 2019, it was already reimbursed by Germany’s third-largest health insurance company.

The Psoriasis App

Based on the proven Nia Health platform, the psoriasis app Sorea was launched in 2020. Established technologies were applied to the needs of patients together with leading clinicians. Sorea is the first psoriasis app that has been approved as a medical device.

The Eczema App

The award-winning eczema app Nia is the most used medical eczema app in Europe. Nia was the first app of its kind to be approved as a medical device. Six months after its release in 2019, it was already reimbursed by Germany’s third-largest health insurance company.

The Psoriasis App

Based on the proven Nia Health platform, the psoriasis app Sorea was launched in 2020. Established technologies were applied to the needs of patients together with leading clinicians. Sorea is the first psoriasis app that has been approved as a medical device.

The Acne App

With the acne app milderma, Nia Health launches its third patient-centric DTx solution. Together with patients and key opinion leaders, a digital companion was developed to support patients with chronic acne. milderma is the first acne app that has been approved as a medical device.

SOON AVAILABLE ON

The Eczema App

The award-winning eczema app Nia is the most used medical eczema app in Europe. Nia was the first app of its kind to be approved as a medical device. Six months after its release in 2019, it was already reimbursed by Germany’s third-largest health insurance company.

The Psoriasis App

Based on the proven Nia Health platform, the psoriasis app Sorea was launched in 2020. Established technologies were applied to the needs of patients together with leading clinicians. Sorea is the first psoriasis app that has been approved as a medical device.

The Acne App

With the acne app milderma, Nia Health launches its third patient-centric DTx solution. Together with patients and key opinion leaders, a digital companion was developed to support patients with chronic acne. milderma is the first acne app that has been approved as a medical device.

We cooperate with Key Opinion Leaders in the field of dermatology and furthermore have successful business angels with interdisciplinary backgrounds working alongside us.

Using digital innovation like Nia Health’s propositions to guide patients through their therapy opens new doors to us doctors by creating a tool that both parties can trust and rely on.

PD Dr. med. Athanasios Tsianakas PD Dr. Tsianakas is the Medical Director of the Department of Dermatology at the Fachklinik Bad Bentheim. As dermatologist with additional specialization in allergology and dermato-oncology his main focus is on chronic inflammatory skin diseases including psoriasis, atopic dermatitis and many others. He underlines that Nia Health is the ideal complement for patients targeting their dermatologic condition. We are pleased to continue our development with PD Dr. Tsianakas and hope to expand the understanding of these diseases. With Dr. Tsianakas' first-hand experience, we will continue to expand our therapeutic solutions.

Offering a future-oriented tool that meets the requirements of a medical device for our patients is inevitable. I look forward to working with Nia Health in realizing patients' needs and further digitalizing the healthcare industry.

Dr. med. Andreas Pinter Since 2013 Dr. Pinter has been the leading senior doctor at the department for Dermatology, Venereology and Allergology at the University Hospital Frankfurt a. M. and member of the Deutsche Dermatologische Gesellschaft (DDG). Dr. Pinter’s focus lies on clinical research and he is also the head of the Center for Studies at the Clinic. As a part of the task force focusing on translational medicine at the Clinic, Dr. Pinter underlines his engagement in fueling the implementation of new diagnostic tools and treatments by using a multi-disciplinary approach such as that provided by Nia Health. This innovative attitude is also mirrored in Dr. Pinter’s university clinic that offers modern technologies enabling individuals to encounter their preferred therapeutic course. We are grateful to welcome a like-minded force on board, who will allow us to optimize patient therapy. With Dr. Pinter’s dermatologic mastery at our disposal we can look forward to observing Nia Health’s growth during the next decades.

The high medical quality of Nia Health’s Apps and especially the great curriculum for sufferers convinced me.

Prof. Dr. med. Regina Treudler As a leading senior doctor at a German University Hospital, Prof. Treudler has proven her outstanding expertise in the world of dermatology for the past decades. Prof. Treudler’s clinical experience also encompasses her practice at an outpatient unit for Clinical Immunology and Asthma and her position as a senior doctor for Dermatology and Allergology at Charité Berlin. Prof. Treudler has gained close to 30 years of experience at Clinics for Dermatology in Germany and currently is head of the clinical ward for Conservative Dermatology and Allergology as well as of the outpatient clinic for Allergology and Occupational Dermatology. Prof.Treudler is also the executive director of a Comprehensive Allergy Center providing her the opportunity to bundle her expertise with other medical professionals. Additionally, Prof. Treudler is a Master of Health Business Administration equipping her with an exceptional skill set in the medical and business realm. We at Nia Health can’t wait to see what this cooperation will have in store for our patients!

    Many challenges have to be mastered to successfully bring a digital medical product to market. Nia Health has already successfully completed the entire process several times. Today, we can leverage our already established platform to launch new DTx solutions even faster.

    IDENTIFICATION
    EVIDENCE
    EVALUATION
    REGISTRATION
    MARKET ACCESS
    OPERATIONS
    COMMERCIALIZATION
    IDENTIFICATION
    Insights from millions of data points from our existing users and interviews with patients & key opinion leaders from our network of medical experts validate high-opportunity propositions.
    EVIDENCE
    As part of our iterative development process, we test our prototype at an extremely early stage with all relevant stakeholders. The proof of concept thus ensures technological and economic feasibility.
    EVALUATION
    We can rely on our strong clinical network when it comes to recruiting matching patients
    REGISTRATION
    We also offer our partners to handle the submission process and to act for them as medical device manufacturer and distributor.
    MARKET ACCESS
    After market approval, data-driven analytics underline the added value of the solution for payers.
    OPERATIONS
    A digital medical device is a living device. Hosting & Maintenance as well as professional handling of patient feedback and complaints require specific know-how.
    COMMERCIALIZATION
    Sustainable success of DTx solutions requires more than state-of-the-art technology and excellent science. Thanks to our in-house marketing expertise and our strong partners, we actually bring DTx solutions to the people who need it.

    Partners

    Nia Health works with key stakeholders across the pharma and healthcare landscape.

    Industry

    Providers

    Payers

    Community

    Our technology behind your project

    Are you interested in an innovative, medical solution based on our proven tech infrastructure? Let’s build something great together!

    Nia Health GmbH is a member of: